Moreover, the experimental treatment was well tolerated, and provided long-lasting tumor control in patients with c-Met mutations, although some responses were also noted in nonmutated patients or in patients with unknown c-Met status, suggesting the action of other alterations of c-Met, as well as alternative pathways [22]. Here, MET is linked to neoplasm.